Function and expression of insulin-like growth factor-binding protein 7 (IGFBP7) gene in childhood acute myeloid leukemia

Pediatric Hematology and Oncology

Volumn 28, Issue 4, 2011, Pages 279-287

  Hu, Shaoyan ^a   Chen, Ruihua ^c   Man, Xiaorui ^a   Feng, Xing ^b   Cen, Jiannong ^c   Gu, Weiying ^c   He, Hailong ^a   Li, Jianqin ^a   Chai, Yihuan ^a   Chen, Zixing ^c  

^a CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b Department of Neonatology ^*  (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

acutemyeloid leukemia (AML); insulin like growth factorbinding protein 7 (IGFBP7) gene; leukemic cell line U937; short interfering RNA (siRNA)

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; MATRIGEL; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CELL ADHESION; CELL ASSAY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHILD; CHILDHOOD LEUKEMIA; COCULTURE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL PROLIFERATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; LEUKEMIA, MYELOID, ACUTE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 79955565792     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2011.557852     Document Type: Article

References (29)

1. Hwa V, Oh Y, Rosenfeld RG.Theinsulin-like growth factor binding protein (IGFBP) superfamily. Endocr Rev. 1999;6:761-787. (Pubitemid 30648894)
2. Collet C, Candy J. How many insulin-like growth factor binding protein? Mol Cell Endocrinol. 1998;139:1-6. (Pubitemid 28340052)
3. Emrick MA, Lee T, Starkey PJ, et al. The gatekeeper residue controls autoactivation of ERK2 via a pathway of intramolecular connectivity. Proc Natl Acad Sci U S A. 2006;103:18101-18106. (Pubitemid 44871619)
4. Formstecher E, Ramos JW, Fauquet M, et al. PEA-15mediates cytoplasmic sequestration of ERKMAP kinase. Dev Cell. 2001;1:239-250. (Pubitemid 33653059)
5. Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A. 1992;89:1827-1831.
6. Campisi J. Suppressing cancer: the importance of being senescent. Science. 2005;309:886-887. (Pubitemid 41099913)
7. Hartman SE, Bertone P, Nath AK, et al. Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev. 2005;19:2953-2968. (Pubitemid 41798112)
8. Hingorani SR, JacobetzMA, Robertson GP, et al. Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res. 2003;63:5198-5202. (Pubitemid 37139827)
9. Hoeflich KP,GrayDC, EbyMT, et al.Oncogenic BRAF is required for tumor growth andmaintenance in melanoma models. Cancer Res. 2006;66:999-1006. (Pubitemid 43165968)
10. Hu SY, Chen ZX, Cen JN, et al.The expression of IGFBP-rP1 in leukemia. Zhonghua Nei Ke Za Zhi. 2005;44:931-932.
11. Heesch S, Schlee C,NeumannM, et al. BAALC-associated gene expression profiles define IGFBP7 as a novel molecularmarker in acute leukemia. Leukemia. 2010;24:1429-1436.
12. Heesch S, BartramI,NeumannM, et al. Expression of IGFBP7 in acute leukemia is regulated byDNA methylation. Cancer Sci. 2011;102:253-259.
13. [Suggestion of diagnosis and treatment of acute myelocytic leukemia in childhood]. Subspecialty Group of Hematology Diseases, The Society of Pediatrics, Chinese Medical Association; Editorial Board, Chinese Journal of Pediatrics. Zhonghua Er Ke Za Zhi. 2006;44:877-878.
14. Murphy M, Pyktt MJ, Harnish P, et al. Identification and characterization of genes differentially expressed inmeningiomas. Cell Growth Differ. 1993;4:715-722.
15. RuanW,XuE,XuF, et al. IGFBP7plays a potential tumor suppressor role incolorectal carcinogenesis. Cancer Biol Ther. 2007;6:354-359. (Pubitemid 47328302)
16. Ma Y, Lu B, Ruan W, et al. Tumor suppressor gene insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) induces senescence-like growth arrest in colorectal cancer cells. Exp Mol Pathol. 2008;85:141-145.
17. Chen Y, Pacyna-Gengelbach M, Ye F, et al. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer. Pathology. 2007;211:431-438. (Pubitemid 46332554)
18. Plymate SR, Haugk KH, Sprenger CC, et al. Increase manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression byMac25/insulin-like growth factor bindingprotein- related protein-1. Oncogene. 2003;22:1024-1034. (Pubitemid 36313146)
19. Chen RY, Chen HX, Lin JX, et al. In-vivo transfection of pcDNA3.1-IGFBP7 inhibits melanoma growth in mice through apoptosis induction and VEGF downexpression. J Exp Clin Cancer Res. 2010;29:13-20.
20. Vizioli MG, Sensi M, Miranda C, et al. IGFBP7: an oncosuppressor gene in thyroid carcinogenesis. Oncogene. 2010;29:3835-3844.
21. Landberg G, Ostlund H, Nielsen NH, et al. Downregulation of the potential suppressor gene IGFBPrP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors. Oncogene. 2001;20:3497-3505. (Pubitemid 32619402)
22. Wajapeyee N, Serra RW, Zhu XC, et al. Oncogenic BRAF Induces Senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008;132:363-374. (Pubitemid 351191995)
23. Scurr LL, Pupo GM, Becker TM, et al. IGFBP7 is not required for B-RAF-induced melanocyte senescence. Cell. 2010;141:717-727.
24. Akaogi K, Sato J, Okabe Y, et al. Synergistic growth stimulation of mouse fibroblasts by tumor-derived adhesion factor with insulin-like growth factors and insulin. Cell Growth Differ. 1996;7:1671-1677. (Pubitemid 26415163)
25. Pen A,MorenoMJ, Durocher Y, et al. Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-â signaling tumor cells induce IGFBP7 in endothelium. Oncogene. 2008;27:6834-6844.
26. van BeijnumJR,Dings RP, VanDer Linden E, et al.Gene expression of tumor angiogenesis dissected; specific targeting of colon cancer angiogenic vasculature. Blood. 2006;108:2339-2348. (Pubitemid 44497518)
27. Akaogi K, Okabe Y, Sato J, et al. Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc Natl Acad Sci U S A. 1996;93:8384-8389. (Pubitemid 26269567)
28. Nagakubo D, Murai T, Tanaka T, et al. A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines. J Immunol. 2003;171:553-561. (Pubitemid 36871361)
29. Solito E, Romero IA, Marullo S, et al. Annexin 1 binds to U937 monocytic cells and inhibits their adhesion to microvascular endothelium: involvement of the á4â1 integrin. J Immunol. 2000;165:1573-1581. (Pubitemid 30604594)